Chronic myelogenous leukemia: recent advances.
暂无分享,去创建一个
[1] J. Burchenal,et al. Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment. , 1982, Blood.
[2] J. Whang‐Peng,et al. Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). , 1968, Blood.
[3] P. Neiman,et al. Treatment of blastic transformation of chronic granulocytic leukemia by chemotherapy, total body irradiation and infusion of cryopreserved autologous marrow. , 1978, Experimental hematology.
[4] G. Cartwright,et al. Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy. , 1961, Blood.
[5] A A Sandberg,et al. Chromosomal abnormalities in human neoplasia. , 1970, Annual review of medicine.
[6] M. Reitz,et al. Transforming potential of human c-sis nucleotide sequences encoding platelet-derived growth factor. , 1984, Science.
[7] S. Lawler. The cytogenetics of chronic granulocytic leukaemia. , 1977, Clinics in haematology.
[8] R. Champlin,et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase. , 1982, Blood.
[9] A. Levine,et al. Chronic myelocytic leukemia: eosinophils involved in the malignant clone. , 1980, Blood.
[10] S. Collins,et al. Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid , 1981 .
[11] A. Baikie,et al. Chronic Granulocytic Leukaemia with Ph1 Negative Cells in Bone Marrow and a Ten Year Remission after Busulphan Hypoplasia , 1972, British journal of haematology.
[12] A. Hagemeijer,et al. Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization. , 1984, Blood.
[13] P. Wiernik. The current status of therapy for and prevention of blast crisis of chronic myelocytic leukemia. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] P. Fialkow,et al. Clonal origin of chronic myelocytic leukemia. , 1973, The New England journal of medicine.
[15] C. Coltman,et al. Response of chronic myelogenous leukemia patients to COAP—splenectomy. A southwest oncology group study , 1984, Cancer.
[16] B. Clarkson. Chronic myelogenous leukemia: is aggressive treatment indicated? , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] R. Smalley,et al. Chronic granulocytic leukemia: cytogenetic conversion of the bone marrow with cycle-specific chemotherapy. , 1977, Blood.
[18] J. Whang‐Peng,et al. Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. , 1977, The American journal of medicine.
[19] M. Groudine,et al. Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. , 1984, Science.
[20] B. Kennedy,et al. Hydroxyurea therapy in chronic myelogenous leukemia , 1972, Cancer.
[21] Susan M. Watanabe,et al. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.
[22] J. Sokal. Evaluation of survival data for chronic myelocytic leukemia , 1976, American journal of hematology.
[23] J. Whang‐Peng,et al. Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy. , 1976, Blood.
[24] R. Silver,et al. Splenectomy in chronic myeloid leukemia. , 1978, Annals of internal medicine.
[25] R F Doolittle,et al. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. , 1983, Science.
[26] N. Wareham,et al. Chemotherapy and autografting for chronic granulocytic leukaemia in transformation: probable prolongation of survival for some patients , 1984, British journal of haematology.
[27] D. Golde,et al. The Philadelphia chromosome in human macrophages. , 1977, Blood.
[28] D. Catovsky,et al. Multiple‐drug chemotherapy for acute leukemia. The TRAMPCOL regimen: Results in 86 patients , 1977, Cancer.
[29] A. Hagemeijer,et al. Chronic myeloid leukemia with permanent disappearance of the Ph1 chromosome and development of new clonal subpopulations. , 1979, Blood.
[30] L. Kearney,et al. T-CELL CYTOGENETICS IN CHRONIC GRANULOCYTIC LEUKAEMIA , 1982, The Lancet.
[31] N. Bersch,et al. Chromosomal mosaicism associated with prolonged remission in chronic myelogenous leukemia , 1976, Cancer.
[32] T. Ruutu,et al. Collection, Cryopreservation and Subsequent Viability of Haemopoietic Stem Cells Intended for Treatment of Chronic Granulocytic Leukaemia in Blast‐Cell Transformation , 1978, British journal of haematology.
[33] V. Najfeld,et al. Involvement of the B-lymphoid system in chronic myelogenous leukaemia , 1980, Nature.
[34] S. Kahn,et al. Myeloproliferative disorders: II CML: clonal evolution and its role in management. , 1979, Leukemia research.
[35] M. Groudine,et al. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[36] V. Najfeld,et al. Evidence for a multistep pathogenesis of chronic myelogenous leukemia. , 1981, Blood.
[37] R. Storb,et al. Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins. , 1982, The New England journal of medicine.
[38] R. Hamman,et al. Busulfan versus hydroxyurea in long‐term therapy of chronic myelogenous leukemia , 1982, Cancer.
[39] D. Golde,et al. Chronic myelogenous leukemia cell growth and maturation in liquid culture. , 1974, Cancer research.
[40] K. Dicke,et al. Allogeneic bone marrow transplantation in man , 1974 .
[41] D. Arthur,et al. SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS IN THE ACCELERATED PHASE OF CHRONIC GRANULOCYTIC LEUKAEMIA , 1982, The Lancet.
[42] J. Gutterman,et al. Human leukocyte interferon to control thrombocytosis in chronic myelogenous leukemia. , 1983, Annals of internal medicine.
[43] O. Witte,et al. Cell lines and clinical isolates derived from Ph '-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration ( chromosome translocation / human leukemia / tyrosine kinase / oncogene ) , 2022 .
[44] J. Laszlo,et al. Treatment of chronic granulocytic leukemia with melphalan , 1978 .
[45] Survival of chronic myeloid leukaemia patients treated by dibromomannitol. , 1973, European Journal of Cancer.
[46] H. Preisler,et al. Chronic myelocytic leukemia: comments on new approaches to therapy. , 1982, Cancer treatment reports.
[47] R. Gale,et al. The early complications of bone marrow transplantation. , 1984, Seminars in hematology.
[48] C. Rozman,et al. A multivariate analysis of prognostic factors in chronic myeloid leukemia. , 1982, Blood.
[49] A. Sandberg,et al. Chromosomes and causation of human cancer and leukemia XVI. Banding studies of chronic myelocytic leukemia, including five unusual Ph1 translocations , 1975, Cancer.
[50] J. Labardini,et al. Late-appearing Philadelphia chromosome in two patients with chronic myelogenous leukemia. , 1980, Blood.
[51] P. Neiman,et al. TREATMENT OF CHRONIC GRANULOCYTIC LEUKAEMIA IN CHRONIC PHASE BY ALLOGENEIC MARROW TRANSPLANTATION , 1982, The Lancet.
[52] R. Silver,et al. Characteristics of the terminal phase of chronic granulocytic leukemia. , 1968, Blood.
[53] E. Canaani,et al. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[54] P. Nowell,et al. Chromosome studies on normal and leukemic human leukocytes. , 1960, Journal of the National Cancer Institute.
[55] M. Lyon. Sex chromatin and gene action in the mammalian X-chromosome. , 1962, American journal of human genetics.